Position
Pfizer Inc in Arvinas, Inc.
Back to the book · All holders of ARVN
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$6.09M$11.86 → $10.10
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 3.46M | $41M | — | — | — | 17.3% |
| Q1 2026 | 3.46M | $34.9M | $10.10 | −$6.09M | $0 | 14.6% |